Adam W. Mailloux

1.3k total citations
44 papers, 979 citations indexed

About

Adam W. Mailloux is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Adam W. Mailloux has authored 44 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 17 papers in Hematology and 13 papers in Oncology. Recurrent topics in Adam W. Mailloux's work include Immune Cell Function and Interaction (15 papers), Acute Myeloid Leukemia Research (10 papers) and Immune cells in cancer (8 papers). Adam W. Mailloux is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Acute Myeloid Leukemia Research (10 papers) and Immune cells in cancer (8 papers). Adam W. Mailloux collaborates with scholars based in United States, China and France. Adam W. Mailloux's co-authors include Matthew R. Young, James J. Mulé, Pearlie K. Epling‐Burnette, Genyuan Zhu, Rana Falahat, Yvan Touitou, A Bogdan, A. Auzéby, Rami S. Komrokji and Alan F. List and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Adam W. Mailloux

41 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam W. Mailloux United States 18 453 269 247 229 180 44 979
Kristopher D. Marjon United States 14 475 1.0× 88 0.3× 159 0.6× 315 1.4× 63 0.3× 22 1.1k
Satsuki Kitano Japan 16 492 1.1× 169 0.6× 39 0.2× 285 1.2× 27 0.1× 37 990
Melanie Hamblen United States 9 398 0.9× 121 0.4× 287 1.2× 460 2.0× 58 0.3× 10 1.4k
Ameya S. Champhekar United States 11 410 0.9× 158 0.6× 51 0.2× 357 1.6× 19 0.1× 15 872
Fabien Agenès France 18 678 1.5× 126 0.5× 57 0.2× 397 1.7× 43 0.2× 25 1.2k
Joseph D. Dekker United States 15 142 0.3× 109 0.4× 36 0.1× 641 2.8× 98 0.5× 30 1.1k
Susanne Reinhardt Germany 19 375 0.8× 78 0.3× 73 0.3× 517 2.3× 32 0.2× 47 1.2k
Philippe Vago France 20 143 0.3× 136 0.5× 25 0.1× 422 1.8× 101 0.6× 89 1.2k
H Saito Japan 12 75 0.2× 137 0.5× 51 0.2× 252 1.1× 73 0.4× 13 672
Duygu Duman Türkiye 19 205 0.5× 29 0.1× 66 0.3× 697 3.0× 73 0.4× 42 1.4k

Countries citing papers authored by Adam W. Mailloux

Since Specialization
Citations

This map shows the geographic impact of Adam W. Mailloux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam W. Mailloux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam W. Mailloux more than expected).

Fields of papers citing papers by Adam W. Mailloux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam W. Mailloux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam W. Mailloux. The network helps show where Adam W. Mailloux may publish in the future.

Co-authorship network of co-authors of Adam W. Mailloux

This figure shows the co-authorship network connecting the top 25 collaborators of Adam W. Mailloux. A scholar is included among the top collaborators of Adam W. Mailloux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam W. Mailloux. Adam W. Mailloux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coleman, Michael F., Eylem Kulkoyluoglu‐Cotul, Emily N. Devericks, et al.. (2024). Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression. Breast Cancer Research. 26(1). 96–96. 1 indexed citations
2.
Smith, Matthew G., et al.. (2023). Abstract 2994: Hypoxia blocks the presentation of tumor antigens to CD8+ T cells. Cancer Research. 83(7_Supplement). 2994–2994. 1 indexed citations
3.
Mulé, James J., et al.. (2021). Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy. Frontiers in Immunology. 12. 675538–675538. 31 indexed citations
4.
Garg, Saurabh, AGM Mostofa, Zhihua Chen, et al.. (2020). Multi-Dimensional Flow Cytometry Analyses Reveal a Dichotomous Role for Nitric Oxide in Melanoma Patients Receiving Immunotherapy. Frontiers in Immunology. 11. 164–164. 8 indexed citations
5.
Brayer, Jason, et al.. (2020). High-Dimensional Flow Cytometry Analysis of Regulatory Receptors on Human T Cells, NK Cells, and NKT Cells. Methods in molecular biology. 2194. 255–290. 3 indexed citations
6.
Falahat, Rana, Patricio Perez-Villarroel, Adam W. Mailloux, et al.. (2019). STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity. Cancer Immunology Research. 7(11). 1837–1848. 67 indexed citations
7.
Zhu, Genyuan, Satoshi Nemoto, Adam W. Mailloux, et al.. (2018). Induction of Tertiary Lymphoid Structures With Antitumor Function by a Lymph Node-Derived Stromal Cell Line. Frontiers in Immunology. 9. 1609–1609. 56 indexed citations
8.
Bartenstein, Matthias, Wanke Zhao, Wan‐Ting Ho, et al.. (2017). Efficacy of ALK5 inhibition in myelofibrosis. JCI Insight. 2(7). e90932–e90932. 34 indexed citations
9.
Robertson‐Tessi, Mark, et al.. (2017). Systematic Screening of Chemokines to Identify Candidates to Model and Create Ectopic Lymph Node Structures for Cancer Immunotherapy. Scientific Reports. 7(1). 15996–15996. 24 indexed citations
10.
Zhu, Genyuan, Rana Falahat, Kui Wang, et al.. (2017). Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering. Frontiers in Immunology. 8. 767–767. 45 indexed citations
11.
Komrokji, Rami S., Adam W. Mailloux, Ling Zhang, et al.. (2014). A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes. Blood. 124(21). 4653–4653. 7 indexed citations
12.
Komrokji, Rami S., Adam W. Mailloux, Mikkael A. Sekeres, et al.. (2014). A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction. Haematologica. 99(7). 1176–1183. 36 indexed citations
13.
Padron, Eric, Jeffrey S. Painter, Sateesh Kunigal, et al.. (2013). GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood. 121(25). 5068–5077. 108 indexed citations
14.
Mailloux, Adam W. & Pearlie K. Epling‐Burnette. (2012). Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes. OncoImmunology. 2(2). e22654–e22654. 17 indexed citations
15.
Padron, Eric, Jeffrey S. Painter, Adam W. Mailloux, et al.. (2011). GM-CSF Signaling Abnormalities in Chronic Myelomonocytic Leukemia. Blood. 118(21). 1713–1713. 2 indexed citations
16.
17.
Mailloux, Adam W., et al.. (2010). NK depletion results in increased CCL22 secretion and Treg levels in Lewis Lung Carcinoma via the accumulation of CCL22‐secreting CD11b+CD11c+ cells. International Journal of Cancer. 127(11). 2598–2611. 16 indexed citations
18.
Mailloux, Adam W. & Matthew R. Young. (2009). NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment. The Journal of Immunology. 182(5). 2753–2765. 69 indexed citations
19.
Mailloux, Adam W., et al.. (2004). GABAB receptor stimulation decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum. Brain Research. 1004(1-2). 18–28. 26 indexed citations
20.
Mailloux, Adam W., et al.. (1999). Body temperature and locomotor activity as marker rhythms of aging of the circadian system in rodents. Experimental Gerontology. 34(6). 733–740. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristopher D. Marjon Breakdown of academic impact, for papers by Satsuki Kitano Breakdown of academic impact, for papers by Melanie Hamblen Breakdown of academic impact, for papers by Ameya S. Champhekar Breakdown of academic impact, for papers by Fabien Agenès Breakdown of academic impact, for papers by Joseph D. Dekker Breakdown of academic impact, for papers by Susanne Reinhardt Breakdown of academic impact, for papers by Philippe Vago Breakdown of academic impact, for papers by H Saito Breakdown of academic impact, for papers by Duygu Duman
Rankless by CCL
2026